OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $792,990 Invested

2020

Neurotrack Technologies, Inc

Kelsey Bryk

Digital Multimodal Neuropsychological Phenotyping for the Detection of Cognitive Decline in Aging Adults

  • Funding Amount: $792,990
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Status: Active